Microscopic kinetics and energetics distinguish GABAA receptor agonists from antagonists

被引:76
|
作者
Jones, MV
Jonas, P
Sahara, Y
Westbrook, GL
机构
[1] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA
[2] Tokyo Med & Dent Univ, Dept Maxillofacial Biol, Tokyo 113, Japan
[3] Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany
[4] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
关键词
D O I
10.1016/S0006-3495(01)75909-7
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Although agonists and competitive antagonists presumably occupy overlapping binding sites on ligand-gated channels, these interactions cannot be identical because agonists cause channel opening whereas antagonists do not. One explanation is that only agonist binding performs enough work on the receptor to cause the conformational changes that lead to gating. This idea is supported by agonist binding rates at GABAA and nicotinic acetylcholine receptors that are slower than expected for a diffusion-limited process, suggesting that agonist binding involves an energy-requiring event. This hypothesis predicts that competitive antagonist binding should require less activation energy than agonist binding. To test this idea, we developed a novel eleconvolution-based method to compare binding and unbinding kinetics of GABAA receptor agonists and antagonists in outside-out patches from rat hippocampal neurons. Agonist and antagonist unbinding rates were steeply correlated with affinity. Unlike the agonists, three of the four antagonists tested had binding rates that were fast, independent of affinity, and could be accounted for by diffusion- and dehydration-limited processes. In contrast, agonist binding involved additional energy-requiring steps, consistent with the idea that channel gating is initiated by agonist-triggered movements within the ligand binding site. Antagonist binding does not appear to produce such movements, and may in fact prevent them.
引用
收藏
页码:2660 / 2670
页数:11
相关论文
共 50 条
  • [31] MCH receptor peptide agonists and antagonists
    MacNeil, Douglas J.
    Bednarek, Maria A.
    PEPTIDES, 2009, 30 (11) : 2008 - 2013
  • [32] Synthetic melanocortin receptor agonists and antagonists
    Lerner, MR
    CUTANEOUS NEUROIMMUNOMODULATION: THE PROOPIOMELANOCORTIN SYSTEM, 1999, 885 : 153 - 160
  • [33] Effects of GABAA and GABAB agonists and antagonists on hypothalamic neurones in vitro.
    Yakimova, K
    Sann, H
    Schmid, HA
    Pierau, FK
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R146 - R146
  • [34] Conformational consensus as a method to distinguish agonists from antagonists II: Identification of selective conformations.
    Tawa, GJ
    Katz, AH
    Alvarez, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U537 - U537
  • [35] Structural determinants for antagonist pharmacology that distinguish the ρ1 GABAC receptor from GABAA receptors
    Zhang, Jianliang
    Xue, Fenqin
    Chang, Yongchang
    MOLECULAR PHARMACOLOGY, 2008, 74 (04) : 941 - 951
  • [36] Two new diterpenoids from the stems of Rhododendron dauricum as GABAA receptor agonists
    Liu, Guo-Sheng
    Zhang, Zhao-Xin
    Su, Guo-zhu
    Wang, Shang-Yi
    Yang, Cheng-Shuo
    Yu, Hai-Bo
    Wang, Ya-Nan
    Li, Yong
    JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2022, 24 (06) : 542 - 549
  • [37] Deactivation kinetics of GABAA receptor isoforms
    Smith, SS
    Gong, H
    BIOPHYSICAL JOURNAL, 2004, 86 (01) : 290A - 291A
  • [38] Application of ensemble learning for predicting GABAA receptor agonists
    Xiao, Fu
    Ding, Xiaoyu
    Shi, Yan
    Wang, Dingyan
    Wang, Yitian
    Cui, Chen
    Zhu, Tingfei
    Chen, Kaixian
    Xiang, Ping
    Luo, Xiaomin
    COMPUTERS IN BIOLOGY AND MEDICINE, 2024, 169
  • [39] GLUCOCORTICOID-RECEPTOR INTERACTIONS - DISCRIMINATION BETWEEN GLUCOCORTICOID AGONISTS AND ANTAGONISTS BY MEANS OF RECEPTOR-BINDING KINETICS
    JONES, TR
    BELL, PA
    BIOCHEMICAL JOURNAL, 1982, 204 (03) : 721 - 729
  • [40] Peptide receptor agonists and antagonists:: From research tools to established drugs
    Varga, G
    Demeter, I
    Ovári, G
    Rácz, GZ
    Burghardt, B
    PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ULCER RESEARCH, 2003, : 143 - 148